Brief: Steven Cohen Reports 5.2% Passive Stake In Arcutis Biotherapeutics As Of Jan 30, 2024 - SEC Filing
31/01/2024 23:04
Jan 31 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O :
* STEVEN COHEN REPORTS 5.2% PASSIVE STAKE IN ARCUTIS
BIOTHERAPEUTICS INC AS OF JAN 30, 2024 - SEC FILING
Source text for Eikon: ID:n0000902664-24-000842
Further company coverage: ARQT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4
Arcutis Q1 product revenue rises 65% yr/yr, net loss narrows
Brief: Arcutis Announces Promotion Of MAS Matsuda To Executive Vice President And Chief Legal Officer To Support Next Phase Of Growth
Brief: Arcutis Begins Enrolling Phase 1A/1B Study Evaluating Arq-234, A Cd200r Agonist, In Healthy Volunteers And Adults With Atopic Dermatitis
Brief: Arcutis Biotherapeutics Inc Files For Mixed Shelf